SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Wednesday reported fourth-quarter net income of $846,000, after reporting a loss in the same period a year earlier.
On a per-share basis, the Seattle-based company said it had profit of 1 cent.
The biotechnology company posted revenue of $14.1 million in the period.
For the year, the company reported that its loss narrowed to $29.3 million, or 52 cents per share. Revenue was reported as $26.3 million.
In the final minutes of trading on Wednesday, the company's shares hit $1. A year ago, they were trading at $4.04.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTIC at https://www.zacks.com/ap/CTIC